Marshall Wace
NSPR icon

Marshall Wace’s InspireMD NSPR Stock Holding History

Marshall Wace’s Portfolio NSPR Stock Details NSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.3M Hold
1,860,405
– – ﹤0.01% 2072
2026
Q1 		$3.03M Hold
1,860,405
– – ﹤0.01% 1561
2025
Q4 		$3.31M Hold
1,860,405
– – ﹤0.01% 1339
2025
Q3 		$4.48M Hold
1,860,405
– – ﹤0.01% 1227
2025
Q2 		$4.22M Hold
1,860,405
– – ﹤0.01% 1225
2025
Q1 		$5M Hold
1,860,405
– – 0.01% 1065
2024
Q4 		$4.87M Hold
1,860,405
– – 0.01% 1070
2024
Q3 		$4.97M Hold
1,860,405
– – 0.01% 1005
2024
Q2 		$4.67M Hold
1,860,405
– – 0.01% 1019
2024
Q1 		$4.28M Hold
1,860,405
– – 0.01% 1058
2023
Q4 		$5.23M Hold
1,860,405
– – 0.01% 891
2023
Q3 		$6.1M Hold
1,860,405
– – 0.01% 799
2023
Q2 		$4.67M Buy
+1,860,405
New +$2.96M 0.01% 1044

Other funds holding NSPR

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
AF
Affiance Financial St. Louis Park, Minnesota $695M AUM 17.33% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

Marshall Wace's NSPR Position: Q2 2026 in Review

Marshall Wace held its InspireMD (NSPR) position steady in Q2 2026 at 1,860,405 shares worth $1.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2072.

Marshall Wace first reported a position in NSPR in Q2 2023 and has held it in 13 quarters since. The position peaked at $6.1M in Q3 2023. 37 funds tracked by Wall St. Rank hold NSPR as of Q2 2026.

  • Marshall Wace held 1,860,405 shares of InspireMD worth $1.3M as of Q2 2026.
  • Marshall Wace left its InspireMD share count unchanged in Q2 2026.
  • InspireMD made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2072 holding.
  • Marshall Wace first reported a position in InspireMD in Q2 2023 and has held it in 13 quarters since.
  • Marshall Wace's InspireMD position peaked at $6.1M in Q3 2023.
  • 37 funds tracked by Wall St. Rank held InspireMD as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.